Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bradley D Shields

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Global Dermatology|September 15, 2018
Proteomics and melanoma: a current perspectiveBradley D Shields, Alan J Tackett, Sara C Shalin
Patient Related Outcome Measures|August 8, 2015
Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgiaLiana D Castel, Kenneth A Wallston, Benjamin R Saville, et al.
Cancer Research|January 25, 2019
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in MelanomaBradley D Shields, Brian Koss, Erin M Taylor, et al.
Scientific Reports|April 13, 2017
Indicators of responsiveness to immune checkpoint inhibitorsBradley D Shields, Fade Mahmoud, Erin M Taylor, et al.
Cancer Research|October 2, 2020
Epigenetic Control of <i>Cdkn2a.Arf</i> Protects Tumor-Infiltrating Lymphocytes from Metabolic ExhaustionBrian Koss, Bradley D Shields, Erin M Taylor, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Global Dermatology|September 15, 2018
Proteomics and melanoma: a current perspectiveBradley D Shields, Alan J Tackett, Sara C Shalin
Patient Related Outcome Measures|August 8, 2015
Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgiaLiana D Castel, Kenneth A Wallston, Benjamin R Saville, et al.
Cancer Research|January 25, 2019
Loss of E-Cadherin Inhibits CD103 Antitumor Activity and Reduces Checkpoint Blockade Responsiveness in MelanomaBradley D Shields, Brian Koss, Erin M Taylor, et al.
Scientific Reports|April 13, 2017
Indicators of responsiveness to immune checkpoint inhibitorsBradley D Shields, Fade Mahmoud, Erin M Taylor, et al.
Cancer Research|October 2, 2020
Epigenetic Control of <i>Cdkn2a.Arf</i> Protects Tumor-Infiltrating Lymphocytes from Metabolic ExhaustionBrian Koss, Bradley D Shields, Erin M Taylor, et al.
Pageof 1